Akeso enrols first patient in phase Ia trial for AK146D1, a bispecific ADC targeting Trop2 and Nectin4: Hong Kong Monday, July 7, 2025, 18:00 Hrs [IST] Akeso, Inc., a leading biop ...

InnoCare receives China NMPA approval to conduct clinical trial of a novel B7-H3 targeted ADC ICP-B794: Beijing Monday, July 7, 2025, 15:00 Hrs [IST] InnoCare Pharma, a leading bi ...

CBI alleges criminal misconduct, exchange of bribe in the acts of PCI president and others: say reports: Our Bureau, New Delhi Monday, July 7, 2025, 16:10 Hrs [IST] The Central Bu ...

Biosynth expands Berlin site with a new commercial bioconjugation suite: Switzerland Monday, July 7, 2025, 17:00 Hrs [IST] Biosynth, a leading developer and supplier of critical r ...

Durham, North Carolina Monday, July 7, 2025, 16:00 Hrs [IST] ...

Karnataka FDA Belagavi, BDR&WPA along with JITO Belgaum, hold awareness rally on drug abuse: Our Bureau, Bengaluru Monday, July 7, 2025, 16:30 Hrs [IST] Karnataka Food Safety & Dr ...

Inventing Hygiene’ campaign to advance standards in pharma instrumentation: Our Bureau, Bengaluru Monday, July 7, 2025, 15:30 Hrs [IST] WIKA Instruments ...

Nxera Pharma to get US$ 4.8 mn in milestone payments following Centessa’s initiation of clinical development of ORX142: Tokyo, Japan Monday, July 7, 2025, 14:00 Hrs [IST] Nxera ...

Nandita Vijayasimha, Bengaluru Monday, July 7, 2025, 08:00 Hrs [IST] ...

UK MHRA approves Serum Life Science Europe’s Anktiva to treat adult patients with non-muscle invasive bladder cancer: United Kingdom Monday, July 7, 2025, 12:00 Hrs [IST] The UK ...

Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...

AB Science receives US FDA & EMA authorization for confirmatory phase 3 trial of masitinib in metastatic castrate resistant prostate cancer: Paris Monday, July 7, 2025, 11:00 Hrs ...